Evidence map›Paper›PMID 34845562›Full record

ReviewClinical rheumatology2022

Long COVID from rheumatology perspective - a narrative review.

Hem Raj Sapkota, Arvind Nune

Abstract readReview
In one paragraph

Review in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Advance in the mechanism and clinical research of myalgia in long COVID.American journal of clinical and experimental immunology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Acute bone loss following SARS-CoV-2 infection in mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  19. Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study.International journal of environmental research and public health · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hem Raj SapkotaThe Royal Wolverhampton Hospital NHS Trust, Wolverhampton, WV10 0QP, UK. Hem.sapkota@nhs.net.ORCID http://orcid.org/0000-0003-2314-2637
Arvind NuneSouthport and Ormskirk NHS Trust, Southport, PR8 6PN, UK.ORCID http://orcid.org/0000-0002-3849-614X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected millions of patients worldwide. Long COVID patients display persistent or relapsing and remitting symptoms that include fatigue, breathlessness, cough, myalgia, arthralgia, sleep disturbance, cognitive impairment and skin rashes. Due to the shared clinical features, laboratory and imaging findings, long COVID could mimic rheumatic disease posing a diagnostic challenge. Our comprehensive literature review will help rheumatologist to be aware of long COVID manifestations and differentiating features from rheumatic diseases to ensure a timely and correct diagnosis is reached.

Indexed as

COVID-19Rheumatic DiseasesRheumatologyHumansPost-Acute COVID-19 SyndromeSARS-CoV-2Long COVIDPost COVID-19 conditionPost-COVID-19 syndromeRheumatologySystemic autoimmune rheumatic diseases

Identifiers

PMID34845562
PMCPMC8629735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.